Zhao, Ting
Li, Hong-jian
Zhang, Hui-lan
Yu, Jing
Feng, Jie
Wang, Ting-ting
Sun, Yan
Yu, Lu-hai
Funding for this research was provided by:
The scientific Research Fund of Pharmaceutical Society of Xinjiang Uygur Autonomous Region (YXH202105)
Article History
Accepted: 10 November 2022
First Online: 23 November 2022
Declarations
:
: This study was supported by the Scientific Research Fund of Pharmaceutical Society of Xinjiang Uygur Autonomous Region (project approval number: YXH202105).
: All authors declare that they have no conflict of interests.
: Approval was obtained from the Ethics Committee of People’s Hospital of Xinjiang Uygur Autonomous Region (Xinjiang, China; Ethical Approval number: KY2019120614).
: Written informed consent was obtained from each patient or legally authorized representative prior to study enrollment.
: Not applicable.
: Not applicable.
: Study design/concept: T.Z., H.-j.L., Y.S., and L.-h.Y. Data acquisition/analysis: all authors. Mentorship and data interpretation: T.Z., H.-j.L., H.-l.Z., J.Y., Y.S. and L.-h.Y. Statistical analysis: T.Z., H.-j.L., and L.-h.Y. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.